Safety, Compatibility and Imaging Quality of ExAblate Prostate Applicator for Prostate Cancer
The objective of this study is to evaluate safety, compatibility and imaging quality of the
ExAblate MRgFUS system for prostate cancer, under simulated use conditions. No acoustic
energy will be delivered and no focused ultrasound therapy will be performed. This is an
imaging only study.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Device-related adverse events
Throughout study period
Yes
Israel: Ethics Commission
PC001
NCT00811265
January 2009
June 2013
Name | Location |
---|